While we have previously dissected CXCL12 signaling in colon, breast, and pancreas solid tumors [9–11], the pharmacologic properties of monomeric and dimeric ligands in hematological malignancies, such as acute myeloid leukemia (AML), remains unknown. The gene discussed is CXCL12; the disease is acute myeloid leukemia.